In our study, the results prompted an increased risk of developing SCC and/or BCC in patients receiving phototherapy vs. anti-TNFα agents, along with the absence of SCC in patients treated with anti-TNFα. This evidence concerns the gene TNF and skin basal cell carcinoma.